The estimated net worth of Ramachandran Murali is at least $191K dollars as of September 24, 2024. Ramachandran Murali is the VP of Research and Development of Kairos Pharma, LTD. and owns shares of Kairos Pharma, LTD. (KAPA) stock worth about $191K.
There are no insider transactions reported by Ramachandran Murali
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.